By Zachary Clemence, Malaria Learning Series Intern at PATH
This post originally appeared on the Making Malaria History blog.
The global scale-up of vector control and improved case management has helped bring malaria cases and deaths to record lows since 2000. Endemic countries and donors are now working toward a world without malaria. Since 2010, PATH, through the Malaria Control and Elimination Partnership in Africa (MACEPA), has been investigating ways to accelerate this process by using drugs to clear parasites from their human hosts. If these approaches, known as population-wide drug-based strategies, are effective, feasible, and affordable, they may reduce malaria transmission in the short term to a level where it could be eliminated through strong surveillance that allows for tracking and treating each case.
This week, PATH released a brief on findings from this research as the first installment of their new Malaria Learning Series. The Learning Series is a suite of reports on current topics in malaria science that will provide practitioners, policymakers, and donors with the most recent evidence for decision-making. Topics will include emerging tools and strategies, health system and surveillance innovations, and planning for elimination.